Jackie Walling

Dr. Walling is the Chief Medical Officer for January Therapeutics. Dr. Walling is a seasoned MD, PhD pharmaceutical executive with extensive experience in the global clinical development of anticancer drugs and drugs for rare genetic diseases. She is also an expert in the technical assessment of licensing opportunities within these fields.

In the field of drug development, Dr. Walling has over 25 years of experience in oncology as well as several years experience in rare genetic disease development.

Dr. Walling has held senior positions at Eli Lilly, Tularik, Axys Pharmaceuticals, BioMarin, in addition to serving as a resident for the UK’s National Health Services.

Dr. Walling received her medical degree from University of Bristol and her PhD from the University of Southampton.